ClinicalTrials.Veeva

Menu

Quality Of Life Outcomes Following Treatment for Esophageal Cancer

Memorial Sloan Kettering Cancer Center (MSK) logo

Memorial Sloan Kettering Cancer Center (MSK)

Status

Completed

Conditions

Esophageal Cancer

Treatments

Behavioral: Questionnaires

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The goal of this study is to evaluate how treatment for esophageal cancer affects your quality of life. The findings of this study may help us understand how this disease and its treatment affect your lifestyle, diet, exercise, support system and overall quality of life. We hope this study will provide important information that can be used to develop programs to improve the quality of life of patients with esophageal cancer.

Full description

In order to determine the impact of esophageal cancer and its treatment on patients' quality of life over time, this study will prospectively follow a cohort of patients at specified intervals, evaluating their physical symptoms, physical and social functioning and overall quality of life. Medical and sociodemographic factors as well as health behaviors that might be predictive of adaptation will be tested. This is a preliminary investigation and it is hoped that we will be able to base future research questions on the results of this study.

Enrollment

409 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 or older
  • Diagnosis of esophageal cancer.
  • Anticipated to undergo surgical resection (Ivor Lewis, Trans Hiatal, McKeown procedure) of esophageal cancer. (Group 1 patients only)
  • Underwent esophagectomy for esophageal cancer at least 18 months prior to consent, with no evidence of disease. (Group 2 patients only)
  • Ability to speak, read and write English.

Exclusion criteria

  • Inability to give informed consent.
  • Patients anticipated to require a laryngectomy as part of their surgical resection.

Trial design

409 participants in 2 patient groups

1
Description:
Group 1 (newly diagnosed patients) Initial assessment → first post op visit → 6 and 12 months post surgery
Treatment:
Behavioral: Questionnaires
2
Description:
Group 2 (post-treatment patients) A one-time assessment will be conducted at least 18 months following treatment
Treatment:
Behavioral: Questionnaires

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems